US11732964B2 - Lyophilization promoting element - Google Patents

Lyophilization promoting element Download PDF

Info

Publication number
US11732964B2
US11732964B2 US17/230,843 US202117230843A US11732964B2 US 11732964 B2 US11732964 B2 US 11732964B2 US 202117230843 A US202117230843 A US 202117230843A US 11732964 B2 US11732964 B2 US 11732964B2
Authority
US
United States
Prior art keywords
lyophilization
base plate
promoting element
apertures
lyophilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US17/230,843
Other languages
English (en)
Other versions
US20210325110A1 (en
Inventor
Mahendra R. Patel
Sandipkumar Arvindbhai Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Navinta III Inc
Original Assignee
Navinta III Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navinta III Inc filed Critical Navinta III Inc
Priority to US17/230,843 priority Critical patent/US11732964B2/en
Priority to PCT/US2021/027435 priority patent/WO2021211806A1/en
Priority to EP21789564.8A priority patent/EP4135516A4/de
Assigned to NAVINTA III INC reassignment NAVINTA III INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PATEL, Sandipkumar Arvindbhai, PATEL, MAHENDRA R.
Publication of US20210325110A1 publication Critical patent/US20210325110A1/en
Application granted granted Critical
Publication of US11732964B2 publication Critical patent/US11732964B2/en
Assigned to PROVIDENT BANK reassignment PROVIDENT BANK SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NAVINTA III INC, NAVINTA NV, INC, NAVINTA, LLC
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00—Heating or cooling apparatus; Heat insulating devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00—Supporting devices; Holding devices
    • B01L9/06—Test-tube stands; Test-tube holders
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B25/00—Details of general application not covered by group F26B21/00 or F26B23/00
    • F26B25/06—Chambers, containers, or receptacles
    • F26B25/063—Movable containers or receptacles, e.g. carts, trolleys, pallet-boxes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0829—Multi-well plates; Microtitration plates

Definitions

  • the present invention relates to pharmaceutical lyophilization manufacturing processes and lyophilized products.
  • the present invention relates to a system and method of use for a lyophilization promoting element.
  • Lyophilization involves the removal of water or other solvents from a given product by a process called sublimation. This occurs when the ice of a frozen product converts directly to the gaseous state without passing through the liquid phase.
  • non-sterile solids are dissolved in solvent to form a solution.
  • the solution is then aseptically filtered through a 0.2 ⁇ sterile grade filter.
  • the filtered solution is filled into a suitable glass container with partial stoppering. Partially stoppered containers are then loaded in a lyophilizer chamber.
  • Vials are often prepared and tightly packed on a tray, which is typically slid out from under the vials after they are loaded on a shelf in the freeze dryer so that the vial bottoms have direct contact with the shelf.
  • vials of product solution are often wrapped with a band (e.g., steel) and placed on a dryer shelf.
  • the system may be referred to as a “bottomless tray” system.
  • vials are loaded directly onto the shelves without the use of trays, although the shelves may have a “ridge” at the edge to prevent vials from falling off the shelf.
  • Lyophilization is performed in three consecutive steps by controlling the temperature of shelves (where the containers are loaded) and the pressure of chamber. These steps are freezing, primary drying, and secondary drying. Lyophilized containers are then fully stoppered and sealed.
  • lyophilizers for the pharmaceutical industry are designed to control temperature of a product by using circulating fluid inside the shelves on which the containers are placed. Desired temperature of the product solution can be achieved by controlling the temperature of the circulating fluid. Heat is transferred from the circulating fluid to the shelf, to the container, and then to the product solution during the primary and secondary drying, while reverse in freezing. The temperature of the product solution is reduced during the freezing process and increased during the primary and the secondary drying. Chamber pressure is reduced (creating vacuum) during the primary and the secondary drying to promote sublimation of frozen material.
  • heat is transferred from or to the solution in three mechanisms of heat transfer, i.e., direct conduction, gas conduction and radiation.
  • Conduction occurs from metal shelves to glass vials, and from surrounding gas molecules to glass vials and solutions, while radiation occurs from surroundings to glass vials in the form of radiant heat.
  • Heat transfer occurs also by means of radiation from a top shelf directly to the solution as shown in FIG. 1 .
  • Direct conduction occurs only from a shelf to the bottom of a vial; gas conduction occurs by means of gas molecules in air; while radiation occurs from all directions. It is generally understood that, in a lyophilization process, the amount of heat transferred via radiation is significantly less than conduction. Gas conduction is greater at higher pressure and less in lower pressure.
  • Tg glass transition temperature
  • edge vials shown in FIG. 2 , have a different heat transfer co-efficient than the center vials, which can cause variation in heat transfer and vial to vial variability. Vials near to the lyophilizer door will have more exposure to radiant heat coming from the door. This will cause faster drying or potential collapse in vials near to the door due to higher product temperature.
  • lyophilization Another issue with product prepared by lyophilization is handling of a vial after filling and loading into lyophilizer.
  • lyophilization is an aseptic operation, handling of filled and half stoppered vials is difficult and results in dropping of the vials online, which increases risk of contamination.
  • the issue is even more acute while handling cytotoxic compounds or potent compounds.
  • VirTis developed a 96-well freeze-drying system, which consists of glass or plastic vials placed in a specially designed aluminum block for uniform heat transfer, which claims to eliminate the atypical edge vial effect seen in standard 96-well plastic plates.
  • the primary purpose is said to be to hold the tubes upright in the metal block and uniformly transfer.
  • Lyocap 96-well capmat stoppers with slots are used to stopper the wells either under vacuum or inert gas.
  • the tubes have a fill volume of 0.5 mL, a tube-like shape, and a flat bottom.
  • the tubes are inserted into black painted aluminum blocks which have precision drillings adjusted to the shape and size of the glass tubes.
  • the blocks consist of a base plate (area of 127 mm ⁇ 85 mm, height of approx.
  • Yalkowski et al. designed a fluid filled cushion of about 1 mm thickness.
  • the soft bag was fabricated from two sheets of aluminium foil lined with polyethylene which were welded by heat. Before the final seal was placed, the bag was filled with glycerine and degassed. This cushion was placed on the freeze dryer shelf and the vials were set on top of it. Since the cushion was flexible the vials “sank in” with the rim of the bottom, the usual line of direct contact. The fluid cushion deformed to fit to the contour of the vial bottom. To maximise contact, Yalkowski and his co-workers applied additional force in the form of an aluminium plate with holes. The holes were placed over the vials' necks.
  • This perforated plate was held in place with clamps fastened to an additional plate fixed underneath the shelf. Using this device, a decrease in primary drying time by over 30% and an increase (approximately 10° C.) in product temperature for molded vials were observed. However, handling of the fluid cushion device is impractical for production cycles.
  • freeze-dried products are now supplied in dual chamber syringes or cartridges.
  • the freeze-dried product is located in one chamber and the diluent is in a second chamber.
  • the product is freeze-dried first and then a stopper is pushed into the syringe barrel to separate the two chambers, and then the diluent is filled in the other chamber.
  • Syringes were placed inside the holes drilled in the aluminum block, which was itself placed on the shelf.
  • the heat transfer was: (a) from the shelf to the aluminum block and (b) from the aluminum block to the syringe. Since the aluminum block is in direct contact with the shelf, the heat is transferred from the shelf to the block by direct heat conduction, conduction through the gas that exists in the gap between the block and the shelf, and via radiation.
  • the syringes did not have direct contact with the shelf as they were suspended above the shelf. Further, the separation distance between the shelf and the syringe was on the order of cm (about 10 mm), and hence there would be relatively less heat transfer via gas conduction.
  • the present invention relates to a system and an element for a pharmaceutical manufacturing process having a lyophilization step that improves the lyophilization step by improving heat transfer between shelves of a lyophilizing chamber and a product container in the chamber.
  • a lyophilization promoting element comprising a base plate comprising a plurality of apertures, the base plate comprising a thermally conductive material, the apertures being regularly arranged within the base plate, and each aperture being sized to receive a pharmaceutical vial container containing a pre-lyophilization solution, wherein the lyophilization promoting element facilitates the transfer of heat between a lyophilizer and the pre-lyophilization solution.
  • the element is capable of accommodating a 2 mL to about 100 mL container, and the container is comprised of glass, plastic, or metal.
  • the base plate comprises a thermally conductive material with a thermal conductivity coefficient ⁇ of about 0.1 to about 400.0 [W/mK] at 20° C. at 1 bar and a co-efficient of linear thermal expansion ⁇ of about 1 to about 25 [10 ⁇ 6 ° C. ⁇ 1 ] at normal temperature.
  • the base plate comprises aluminum or an oxide of aluminum.
  • the base plate comprises a hollow polymeric material and a fluid with a negative thermal expansion property.
  • each of the plurality of apertures is cylindrical and has a diameter between 5 and 100 millimeters. In some of those embodiments, each of the plurality of apertures is cylindrical and has a diameter between 10 and 80 millimeters, most preferably about 15 mm to about 48 mm.
  • each of the plurality of apertures comprises a circumferential wall and is sized to allow a tolerance of no more than 0.5 millimeters between the circumferential wall and an outer wall of an inserted pharmaceutical vial container.
  • the base plate has a vertical thickness between 10 and 200 millimeters. In some of those embodiments, the base plate has a vertical thickness between 20 and 100 millimeters.
  • the base plate comprises a surface area and the plurality of apertures occupy more than 50% of the surface area. In certain of those embodiments, the base plate comprises a surface area and the plurality of apertures occupy more than 80% of the surface area.
  • At least one of the plurality of apertures extends entirely through a vertical thickness of the base plate.
  • At least one of the plurality of apertures extends only partially through a vertical thickness of the base plate.
  • each of the plurality of apertures further comprises a radial groove, the radial groove expanding outwardly from a circumferential wall of each aperture adjacent to a top surface of the base plate.
  • each radial groove extends at an angle of approximately 45 degrees to a depth of approximately 0.5 to 10 millimeters from the top surface of the base plate down to the circumferential wall of each aperture, more preferably about 2.5 mm to about 6.5 mm.
  • each of the plurality of apertures extends only partially through a vertical thickness of the base plate and the base plate further comprises a plurality of protrusions extending up from the base plate into each of the plurality of apertures.
  • the protrusions are sized and shaped to match an internal bore provided in a bottom of an inserted pharmaceutical vial container, said internal bore extending upwardly into an interior of said inserted pharmaceutical vial container.
  • the base plate comprises a first portion comprised of a primary material and a second portion comprised of a secondary material, the second portion being located adjacent to a circumferential wall of each of the plurality of apertures.
  • each of the plurality of apertures extends entirely through a vertical thickness of the base plate and further comprises a radial ridge, the radial ridge extending inwardly from a circumferential wall of each aperture adjacent to a bottom surface of the base plate.
  • each radial ridge extends at an angle of approximately 45 degrees to a height of approximately 1.5 to 4 millimeters from the bottom surface of the base plate up into each aperture to meet the circumferential wall of each aperture.
  • each of the plurality of apertures further comprises at least one side channel that permits the passage of air, said side channel having a width no greater than 10% of a perimeter of the aperture.
  • each of the plurality of apertures has an associated reference number affixed to the base plate to facilitate tracking of any inserted pharmaceutical vial containers for investigatory purposes.
  • a method of lyophilization comprises the steps of providing the lyophilization promoting element described herein, providing one or more pharmaceutical vial containers containing a pre-lyophilization solution or suspension, the one or more pharmaceutical vial containers being half stoppered, inserting the one or more pharmaceutical vial containers into the plurality of apertures of the lyophilization promoting element, placing the lyophilization promoting element holding the one or more pharmaceutical vial containers on a shelf of a lyophilizer, closing a door to the lyophilizer and initiating the lyophilization process, said lyophilization process comprising the steps of freezing, primary drying, and secondary drying, removing the lyophilization promoting element holding the one or more pharmaceutical vial containers from the lyophilizer, and fully stoppering and sealing the one or more pharmaceutical vial containers.
  • the method further comprises the steps of providing a tray, placing the lyophilization promoting element holding the one or more pharmaceutical vial containers on the tray, placing the tray and the lyophilization promoting element holding the one or more pharmaceutical vial containers on the shelf of the lyophilizer, removing the tray from between the shelf of the lyophilizer and the lyophilization promoting element, leaving the lyophilization promoting element holding the one or more pharmaceutical vial containers on the shelf of the lyophilizer; and reinserting the tray between the lyophilizer shelf and the lyophilization promoting element and removing the tray and the lyophilization promoting element holding the one or more pharmaceutical vial containers from the lyophilizer upon completion of the lyophilization process.
  • a third aspect of the invention is a system to enhance thermal conduction in a freeze-drying process comprising: a lyophilizer having a plurality of shelves, and an element having one or more pockets, wherein the element is placed between a lyophilizer shelf and a sample container containing a pre-lyophilization solution.
  • the element has a cuboidal shape.
  • the element is comprised of metal, alloy of metals, oxide of metals or a combination thereof.
  • the pockets are hollow.
  • the pocket is capable of accommodating a 2 mL to about 100 mL container, and the container is comprised of glass, plastic, or metal.
  • the element is comprised of polymeric material.
  • the element is hollow and contains thermal conductible fluid in the hollowed portion.
  • the fluid comprises water or oil.
  • the fluid expands on cooling.
  • the element has radial groves within a pocket.
  • a robotic filling line is used to place/fill a vial within a pocket.
  • the one or more pockets are numbered to facilitate locating the position of vials in the lyophilizer.
  • the system further comprises a modified tray or shelf in the lyophilizer that has an increased surface area.
  • the element further comprises a material selected from the group consisting of thermal conductive polymer, polymer-metal composite, Ionic polymer metal composite, polymer matrix composite, and combinations thereof.
  • the material is in contact with the one more containers containing pre-lyophilization solution from a side wall, bottom, or both.
  • the system further comprises a block or tube containing the one or more containers containing a pre-lyophilization solution.
  • the block or tube is made up of metal-polymer composite, metal infused polymer, polymer or metal.
  • the block or tube is in contact with the one more containers containing a pre-lyophilization solution from one or more of an outer wall or bottom.
  • the invention provides a method of using the described system, wherein one or more of the containers are filled and/or half stoppered.
  • the method comprises placing the one or more filled and/or half stoppered containers in a pocket of the element, placing the element on a tray or a moving belt, transferring the element to one of the plurality of shelves of the lyophilizer, removing the element after completion of a freeze-drying process, and taking the one or more containers out of the pocket.
  • a robotic filling line is used to place/fill a vial within a pocket.
  • the pocket is capable of accommodating a 2 mL to about 100 mL container, and the container is comprised of glass, plastic, or metal.
  • the invention provides a modified USP type I glass container for a lyophilization process, the container comprising: a top having an opening extending to a bottom, a height, and a width.
  • the height is shorter than the width and the bottom is flat.
  • the bottom has a hollow shape.
  • the hollow part consists of different shapes, such as but not limited to, cylinder, cone, and cylinder with a round surface at the end.
  • Such modified containers are easier to handle, have a greater surface area for heat transfer, and can be accommodated with robotic handling.
  • the invention also relates to a system for improving lyophilization process in a lyophilizer having a plurality of shelves that is able to reduce vial-to-vial variability in residual solvent after a lyophilization process.
  • the system includes use of an element having one or more pockets, wherein the element is placed between a lyophilizer shelf and a sample container containing a pre-lyophilization solution. The element holds a container containing a pharmaceutical solution within a pocket during the lyophilization process.
  • the element allows direct contact of at least one surface of the container with the lyophilizer shelf during the lyophilization process.
  • FIG. 1 shows a partial cross-sectional view from the side of a pharmaceutical vial loaded on the shelf of an exemplary, generally-known lyophilizer using methods known in the prior art.
  • FIG. 2 shows a cross-sectional view from above of an exemplary, generally-known lyophilizer shelf filled with a plurality of vials using methods known in the prior art.
  • FIG. 3 a shows a front perspective view of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 3 b shows an orthogonal view from above of a lyophilization promoting element according to exemplary embodiments of the present invention as depicted in FIG. 3 a.
  • FIG. 3 c shows a cross-sectional view from the side of a lyophilization promoting element according to exemplary embodiments of the present invention as depicted in FIGS. 3 a and 3 b.
  • FIG. 4 a shows an orthogonal view from above of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 4 b shows a cross-sectional view from the side of a lyophilization promoting element according to exemplary embodiments of the present invention as depicted in FIG. 4 a.
  • FIG. 4 c shows a blown-up, front perspective view of a pocket of a lyophilization promoting element according to exemplary embodiments of the present invention as depicted in FIGS. 4 a and 4 b.
  • FIG. 5 shows a schematic depiction of the installation of a lyophilization promoting element onto a lyophilizer shelf for processing according to exemplary embodiments of the present invention.
  • FIG. 6 a shows a cross-sectional view from the side of a bottom hollow pharmaceutical vial container according to exemplary embodiments of the present invention.
  • FIG. 6 b shows a cross-sectional view from the side of a bottom hollow pharmaceutical vial container according to exemplary embodiments of the present invention.
  • FIG. 6 c shows a cross-sectional view from the side of a bottom hollow pharmaceutical vial container according to exemplary embodiments of the present invention.
  • FIG. 7 shows a series of cross-sectional views from the side of lyophilization promoting elements according to exemplary embodiments of the present invention loaded with bottom hollow pharmaceutical vial containers according to exemplary embodiments of the present invention as depicted in FIGS. 6 a - 6 c.
  • FIG. 8 shows an orthogonal view from above of a lyophilization promoting element according to exemplary embodiments of the present invention as depicted in FIG. 7 .
  • FIG. 9 a shows a cross-sectional view from the side and an orthogonal view from above of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 9 b shows a close-up, cross-sectional view from the side of a pocket of the lyophilization promoting element depicted in FIG. 9 a.
  • FIG. 10 shows a cross-sectional view of a pharmaceutical vial container within a pocket of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 11 shows a cross-sectional view of a pharmaceutical vial container within a pocket of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 12 shows a cross-sectional view of a pharmaceutical vial container within a pocket of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 13 shows a cross-sectional view of a pharmaceutical vial container within a pocket of a lyophilization promoting element according to exemplary embodiments of the present invention.
  • FIG. 14 a shows a front perspective view of a flat-bottom, short height pharmaceutical vial container according to exemplary embodiments of the present invention.
  • FIG. 14 b shows a front perspective view of a flat-bottom, short height pharmaceutical vial container according to exemplary embodiments of the present invention.
  • lyophilization also known as freeze-drying, lyophilisation, or cryodesiccation
  • freezing means a process of removal water or other solvents by freezing a material containing water and/or other solvents followed by reducing the surrounding pressure to allow the frozen water and/or other solvents in the material to sublimate directly from the solid phase to the gas phase.
  • lyophilization is meant to involve three phases: freezing, primary drying, and secondary drying.
  • Lyophilization is performed within a lyophilizer.
  • the lyophilizer will have a lyophilizing chamber in which containers of product to be lyophilized are placed.
  • the lyophilizing chamber contains one or more shelves on which the containers are placed. Typically, a plurality of shelves is used in the lyophilizing chamber during the lyophilization process.
  • the lyophilizer is used to remove solvent from a pharmaceutical product solution.
  • product solution is meant to refer to any liquid mixture containing one or more pharmaceutical solids and a pharmaceutically acceptable solvent. The solid may be fully dissolved or dispersed within the solvent.
  • FIGS. 1 and 2 depict vials in a lyophilization process according to known methods.
  • FIG. 1 depicts a single pharmaceutical container 12 placed upon a shelf 14 within the lyophilizer.
  • the container 12 contains a product solution 16 intended to undergo the lyophilization process.
  • FIG. 2 a plurality of containers 12 are placed upon the shelf 14 in the lyophilizer, surrounded by side walls 18 , a back wall 20 , and a front door 22 .
  • Many lyophilizers employ several shelves 14 to hold a plurality of containers 12 each, and the containers 12 are also surrounded by an additional shelf 14 above accordingly, as depicted in FIG. 1 , or by the top of the lyophilizer (not depicted).
  • the containers 12 are loaded into the lyophilizer upon the several shelves 14 , and the door 22 to the lyophilizer is closed to create an enclosed space.
  • the three steps of the lyophilization process are then performed—freezing, primary drying, and secondary drying—and the containers 12 are then removed from the lyophilizer and sealed for packaging and transport.
  • the present invention improves upon the lyophilization process by encompassing the plurality of containers 12 with a lyophilization promoting element 24 .
  • the element 24 includes one or more holes/openings or “pockets” 26 to accommodate each container 12 for lyophilization.
  • the element is formed of a thermally conductive material having a thermal conductivity coefficient ⁇ of about 0.1 to about 400.0 [W/mK] at 20° C. at 1 bar and a co-efficient of linear thermal expansion ⁇ of about 1 to about 25 [10 ⁇ 6 ° C. ⁇ 1 ] at normal temperature.
  • the height/depth of the pockets 26 may be about 5 mm to about 100 mm, or more preferably from about 10 mm to 80 mm and the width or diameter typically will be about 5 mm to about 30 mm, more preferably about 10 mm to about 25 mm. Most preferably, the height is about 20 mm to about 75 mm and diameter is about 15 mm to about 48 mm.
  • the pocket size is adapted to the size of container 12 and will allow a tolerance of about 0.05 mm to about 0.5 mm between the circumferential wall 30 of the pocket 26 and outer wall of container 12 .
  • the thickness of the element 24 is preferably about 10 mm to 200 mm, and more preferably between 20 mm and 100 mm.
  • the area of the element 24 occupied by the pockets 26 is preferably more than 20% of total area when observed from above, more preferably more than 50%, and even more preferably more than 80%.
  • the pockets 26 extend through the entire thickness of the element 24 such that a bottom edge of the container 12 is visible and accessible when the container 12 is installed within the element 24 . In other preferable embodiments, the pockets 26 extend only partially through the thickness of the element 24 , creating a lower surface of the pockets 26 upon which the bottom edge of the containers 12 may rest when the containers are installed within the element 24 . In preferable embodiments, the pockets 26 are sized to provide a snug fit for containers 12 contained therein such that the containers 12 do not fall through the element 24 when the element 24 is lifted, regardless of which preferable embodiment is used.
  • the container 12 will typically be a vial used to contain a liquid formulation and may be glass or glass-like vials or other suitably sterile transparent vials that are commercially available from various suppliers, including Nuova Ompi, Schott AG, or Daikyo Seiko, Ltd, for example.
  • Pharmaceutical containers made from tubular glass are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-1 standard. Molded glass vials are commercially available in a range of different sizes with dimensions according to the DIN/ISO 8362-4 standard.
  • Particularly suitable glass containers are those described in 36 USP ⁇ 660>/EP 3.2.1 Glass Containers for Pharmaceutical Use (2017).
  • Glass has traditionally been the only choice for container material but problems with glass breakage, delamination, particulates due to glass-on-glass collisions, and stability of some products resulted in development and usage of suitable polymeric materials.
  • polymeric material is TOPAS® cyclic olefin polymer.
  • Vials made of polymeric materials are commercially available in size ranges and dimensions that typically closely mimic those of glass vials.
  • Polymeric materials are significantly less scratch resistant than glass and existing aseptic processing equipment has not been redesigned to mitigate the risks of scratching. Scratched surfaces of containers are a serious concern for the perceived quality of the product, but also severely limits the inspection of the containers for particulates. Such inspection is typically a regulated requirement for good manufacturing practice.
  • the pocket 26 is adapted to contain a size 2R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R or 100R injection vial.
  • the container 12 may further include a suitable stopper, such as commercially available elastomeric stoppers, e.g., those made or distributed by Daikyo Seiko, Ltd or West Pharmaceutical Services, Inc.
  • the pocket 26 have a depth that allows it to envelope the side wall portion of container 12 containing the solution 16 at least up to the height of the solution.
  • the pocket will have a depth sufficient to envelope 25%, more preferably 50% to 75% of the height (excluding neck) of a vial.
  • the depth of the pocket 26 is sufficient to surround the body of a vial but does not cover the vial neck.
  • the depth of the pocket 26 is substantially similar to a height (excluding neck) of a standard size injection vial. In other embodiment, the depth of the pocket 26 is substantially similar to the height (including neck) of a vial.
  • the element 24 of the present invention may be made up of polymeric material.
  • the polymeric material can be hollow or filled with fluid having negative thermal expansion property, i.e., the fluid expands upon cooling, which can help to improve intimate contact of the element 24 and containers 12 placed within.
  • FIG. 4 a depicted is a preferable embodiment of the lyophilization promoting element 24 with a plurality of pockets 26 arranged in a 6 ⁇ 15, standard spaced arrangement.
  • a rectangular, 6 ⁇ 15 arrangement is just one example of how the pockets 26 may be arranged in the element 24 , and other shapes, sizes, and spacings are likewise available and are included in this disclosure.
  • commercially available trays typically have 60-120 containers, the quantity varying with vial diameter.
  • the number and arrangement of pockets 26 can match the vial configurations of commercially available trays as well as nests/supporting structures disclosed in, e.g., U.S. Pat. Nos. 9,522,752 and 10,781,003 and/or commercially available from known vial suppliers.
  • the pockets 26 include a radial groove 28 extending outwardly from the outer circumference of the pockets 26 .
  • the radial groove 28 is cut out of the top surface of the element 24 and preferably extends radially and at a consistent angle from the top surface of the element, where the groove's 28 radius is largest, to the pocket's 26 outer circumference, where the groove's 28 radius is smallest and matches the pocket's 26 radius.
  • the radial groove's 28 angle is preferably between 30 and 60 degrees, and more preferably approximately 45 degrees.
  • the radial grooves 28 extend from the top surface of the element 24 to a preferable depth of between 0.5 and 10 millimeters, and more preferably to a depth of approximately 2.5 to about 6.5 millimeters.
  • the radial grooves 28 accommodate smooth placement of the containers 12 into element 24 from any direction.
  • FIG. 5 depicts the use of the preferable embodiment of the lyophilization promoting element 24 depicted in FIG. 4 a to introduce a series of containers 12 into a lyophilizer.
  • the element 24 may be used in conjunction with a tray 32 to facilitate the installation and removal of the element 24 and containers 12 arranged therein.
  • Containers 12 are first placed within the pockets 26 of element 24 , with or without tray 32 .
  • the element 24 is then inserted into the lyophilizer and placed down upon the lyophilizer shelf 14 .
  • the tray 32 is then slid out from under the element 24 and containers 12 and removed from the lyophilizer while the element 24 and containers 12 remain resting on the lyophilizer shelf 14 .
  • the lyophilization process then occurs, and the element 24 and containers 12 are removed from the lyophilizer once complete, either by sliding tray 32 between the element 24 and lyophilizer shelf 14 or by simply removing the element 24 with inserted containers 12 on its own where no tray 32 is employed.
  • preferable embodiments of the lyophilization promoting element 24 employ pockets 26 sized to accommodate containers 12 snugly such that they remain removably held within the element 24 when the element 24 is being removed, manipulated, and/or transferred even in preferable embodiments in which the pockets 26 extend through the entire thickness of the element 24 .
  • Such unique containers 12 referred to herein as bottom-hollow containers 12 , employ an internal bore 34 that extends up from the bottom edge of the container 12 into the container's interior 36 .
  • the internal bore 34 increases the contact surface area of the container's 12 outer surface and the lyophilization promoting element 24 , improving the performance of heat transfer to and from the product solution 16 within the containers 12 .
  • FIGS. 6 a - 6 c Various shapes are available for the internal bore 34 , including but not limited to those depicted in FIGS. 6 a - 6 c —cone, cylinder, and cylinder with rounded top—among others. As those of skill in the art will appreciate, any internal bore 34 shape that increases the contact surface area between the container 12 and the element 24 will have the intended effect of increasing heat transfer to and from product solution 16 .
  • FIG. 7 the unique containers 12 from FIGS. 6 a - 6 c are depicted in use with a preferable embodiment of the lyophilization promoting element 24 , which employs a protrusion 38 extending from the lower end of the pocket 26 up into pocket 26 and is preferably shaped to match the internal bore 34 provided in the unique container 12 design.
  • the protrusion's 38 shape need not perfectly or even closely match the internal bore's 34 shape, but a more closely matching shape between the internal bore 34 and protrusion 38 will increase the contact surface area between the container 12 and element 24 , as those of skill in the art will recognize.
  • FIG. 8 depicts a top down view of the preferable embodiment of element 24 from FIG. 7 c , wherein the containers 12 have been removed, and visible is element 24 with a plurality of pockets 26 employing radial grooves 28 and protrusions 38 .
  • a preferable embodiment of the lyophilization promoting element 24 with a primary portion 42 and a secondary portion 44 preferably employ a first material for the primary portion 42 , which makes up the vast majority of element 24 , and a second material for the secondary portion 44 , which is present only directly adjacent to the circumferential wall 30 of one or more of the pockets 26 .
  • a secondary portion 44 comprising a second material directly adjacent to the circumferential wall 30 of pockets 26 (and thus to the containers 12 when installed)
  • more costly materials more effective at direct conduction heat transfer may be employed efficiently and only where most effective, while the remaining primary portion 42 of the element 24 may be made of another, less costly material.
  • Such preferable embodiments help to maximize the efficiency of heat transfer between the lyophilizer and the product solution 16 within the containers 12 during the lyophilization process.
  • FIGS. 10 - 13 a series of containers 12 containing product solutions 16 installed within preferable embodiments of lyophilization promoting elements 24 are depicted.
  • FIG. 10 depicts a container 12 in element 24 with pocket 26 that does not extend through the entire thickness of element 24 , thereby creating a lower surface of pocket 26 upon which container 12 rests.
  • FIG. 11 depicts a similar arrangement, however the pocket 26 depicted in FIG. 11 does extend through the entire thickness of element 24 , permitting access of the lyophilizer shelf to the bottom 48 of the container 12 .
  • the element 24 employs a plurality of pockets 26 all of which either extend entirely through the element's 24 thickness or do not, other embodiments may employ a plurality of both.
  • some embodiments of the element 24 may include a plurality of pockets 26 that extend through the entire thickness of the element and a plurality of pockets 26 that do not, or any combination thereof, as those of skill in the art will appreciate.
  • FIGS. 12 and 13 are similar to FIGS. 10 and 11 , respectively, but also depict secondary portion 44 of element 24 comprising a second material directly adjacent to the installed containers 12 .
  • the secondary portion may be utilized to improve the efficiency of heat transfer between the lyophilizer and the product solution 16 within the containers 12 during the lyophilization process.
  • FIGS. 11 and 13 specifically, depicted are lyophilization promoting elements 24 with pockets 26 extending through the elements' 24 entire thickness. This is notable because, as discussed above, element 24 is intended to facilitate moving the containers 12 as a group, and the containers 12 must accordingly fit snugly within pockets 26 to avoid dropping out of the bottom of elements 24 when the pockets 26 extend the entire length of the elements 24 .
  • the pockets 26 employ a radial ridge 46 extending from the lower edge of the element 24 into the pockets 26 .
  • This radial ridge 46 is preferably sized and shaped to support the containers 12 from below when they are installed in the element 24 .
  • the radial ridge 46 preferably extends at an angle from the lower edge of the element 24 , at which point the radial ridge extends furthest into pocket 26 , up into the pocket 26 a short distance, wherein it meets the circumferential wall 30 of the pocket 26 .
  • the radial ridge's 46 angle is preferably between 30 and 60 degrees, and more preferably approximately 45 degrees.
  • the radial ridge 46 preferably extends no further than 0.5 millimeters to 6 millimeters from the element's 24 lower edge up into the pocket 26 , and more preferably extends to a height of approximately 1.5 millimeters to 4 millimeters. Whatever the arrangement of radial ridge 46 , the bottom 48 of the container 12 should preferably sit flush with or protrude slightly below the lower edge of the element 24 , as depicted in FIGS. 11 and 13 .
  • the pockets 26 have side channels to permit air displacement while inserting the containers 12 into the pockets 26 .
  • the side channel feature is particularly useful in preferable embodiments in which the pockets 26 do not extend through the entire thickness of the element 24 , creating a lower surface of the pockets 26 upon which the bottom 48 of the containers 12 may rest when the containers 12 are installed within the element 24 .
  • Such side channels preferably have a width of about 1% to 10% of the total perimeter of the pockets 26 .
  • the side channels may be cylindrical or cubical or any other shape that can assist with the passage of air, as will be understood by those of skill in the art.
  • the pockets 26 are numbered by engraving, printing, or embossing to locate the position of a container 12 on the shelf before lyophilization, and also after lyophilization. Such numbering can help in sampling or investigation.
  • flat-bottom, short-height containers 12 Such flat-bottom, short height containers 12 improve the effective heat transfer between the lyophilizer and the product solution 16 by increasing the contact surface area between the container 12 and the element 24 or the lyophilizer shelf 14 , similar to the advantages provided by the bottom-hollow containers 12 depicted in FIGS. 6 - 7 . Because the flat-bottom, short-height containers 12 have a large bottom surface area, the product solution 16 is more spread out and more effectively subjected to direct conduction heat transfer. Preferable embodiments of the flat-bottom, short height containers 12 may be used in conjunction with preferable embodiments of the lyophilization promoting elements 24 or may be placed directly upon the lyophilizer shelf 14 without losing any significant heat transfer effectiveness.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
US17/230,843 2020-04-15 2021-04-14 Lyophilization promoting element Active 2041-10-28 US11732964B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US17/230,843 US11732964B2 (en) 2020-04-15 2021-04-14 Lyophilization promoting element
PCT/US2021/027435 WO2021211806A1 (en) 2020-04-15 2021-04-15 Lyophilization promoting element
EP21789564.8A EP4135516A4 (de) 2020-04-15 2021-04-15 Lyophilisierungsförderndes element

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063010283P 2020-04-15 2020-04-15
US17/230,843 US11732964B2 (en) 2020-04-15 2021-04-14 Lyophilization promoting element

Publications (2)

Publication Number Publication Date
US20210325110A1 US20210325110A1 (en) 2021-10-21
US11732964B2 true US11732964B2 (en) 2023-08-22

Family

ID=78081334

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/230,843 Active 2041-10-28 US11732964B2 (en) 2020-04-15 2021-04-14 Lyophilization promoting element

Country Status (3)

Country Link
US (1) US11732964B2 (de)
EP (1) EP4135516A4 (de)
WO (1) WO2021211806A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220307767A1 (en) * 2021-03-24 2022-09-29 Torsten Pächnatz Freeze drying plant and method
US20230040871A1 (en) * 2020-02-24 2023-02-09 Candry Technologies Inc. Dehydrating apparatus and method
US12379157B2 (en) * 2022-06-28 2025-08-05 Compliance Consulting And Engineering Services, S.L. System for controlling the freeze-drying process in a freeze dryer with a plate stack system and a method for generating a design space

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729616B2 (en) * 2014-08-04 2020-08-04 Genentech, Inc. Apparatus and methods for sealing a medicament within a medical delivery device
US11732964B2 (en) * 2020-04-15 2023-08-22 Navinta Iii Inc Lyophilization promoting element

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US5522155A (en) * 1994-08-19 1996-06-04 W. L. Gore & Associates, Inc. Vented vial method of minimizing contamination of freeze-dried products
US5937536A (en) * 1997-10-06 1999-08-17 Pharmacopeia, Inc. Rapid drying oven for providing rapid drying of multiple samples
US6419827B1 (en) 1998-10-29 2002-07-16 Applera Corporation Purification apparatus and method
US20130025298A1 (en) 2011-07-28 2013-01-31 Biocision, Inc. Preventing sample degradation from transient temperature fluctuations
US8516714B2 (en) * 2008-01-21 2013-08-27 Intervet International B.V. Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles
US8528225B2 (en) * 2009-12-11 2013-09-10 Wyssmont Company Inc. Apparatus and method for continuous lyophilization
US8793896B2 (en) * 2010-02-01 2014-08-05 Adixen Vacuum Products Device and method for controlling a dehydration operation during a freeze-drying treatment
KR20150009982A (ko) * 2012-05-03 2015-01-27 쇼오트 아게 의료, 제약 또는 화장품 어플리케이션들을 위한 물질들을 저장하기 위한 컨테이너들을 처리하기 위한 방법 및 장치
US20150108034A1 (en) 2013-10-21 2015-04-23 Schott Ag Supporting structure for supporting containers for substances for medical, pharmaceutical or cosmetic applications as well as transport and packaging container comprising the same
CN106461327A (zh) 2014-06-09 2017-02-22 泰尔茂比司特公司 冻干法
WO2017137637A2 (en) * 2016-08-05 2017-08-17 Bachem Holding Ag Drying container
US20180148222A1 (en) 2016-11-30 2018-05-31 Schott Ag Supporting structure for concurrently supporting a plurality of vials, use thereof and process for the treatment of such vials
US10085971B2 (en) * 2016-08-22 2018-10-02 Navinta Iii Inc Pharmaceutical solution of asenapine for sublingual or buccal use
AU2016208368B2 (en) 2010-08-06 2019-05-02 Hospira Australia Pty Ltd Vial preparation method and system
EP3499160A1 (de) 2017-12-15 2019-06-19 Martin Christ Gefriertrocknungsanlagen GmbH Gefriertrockner, gefriertrocknungsanlage, verfahren zum betrieb eines gefriertrockners und neue verwendung eines schlittens
US10342769B2 (en) * 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
CN110180607A (zh) 2013-03-14 2019-08-30 简·探针公司 用于执行自动试剂分析的系统、方法和设备
US20190285342A1 (en) 2015-09-22 2019-09-19 Millrock Technology, Inc. Apparatus and method for developing freeze drying protocols using small batches of product
US10781003B2 (en) 2013-08-16 2020-09-22 Vanrx Pharmasystems Inc. Method, system, and apparatus for pharmaceutical container filing and lyophilizing
US11054185B1 (en) * 2020-02-24 2021-07-06 Lyophilization Technology, Inc. Apparatus for lyophilization of products contained in product delivery units
US20210325110A1 (en) * 2020-04-15 2021-10-21 Navinta Iii Inc Lyophilization Promoting Element
US11243029B2 (en) * 2019-04-26 2022-02-08 Purdue Research Foundation Process monitoring and control for lyophilization using a wireless sensor network
US11359860B2 (en) * 2018-09-10 2022-06-14 Michael B. McNeil Herb essential oil processing equipment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6199297B1 (en) * 1999-02-01 2001-03-13 Integrated Biosystems, Inc. Lyophilization apparatus and methods
JP4705035B2 (ja) * 2003-05-23 2011-06-22 バイオ−ラッド ラボラトリーズ，インコーポレイティド 反応培地の空間配列に対し局部化した温度制御
JP5334299B2 (ja) * 2008-07-18 2013-11-06 味の素株式会社 検体試験管冷却・保冷装置、該装置を有するシステム、および、該装置の使用方法
KR101995767B1 (ko) * 2013-01-11 2019-07-03 리제너론 파마슈티칼스 인코포레이티드 샘플 관리를 위한 시스템들 및 디바이스들
CN106513078B (zh) * 2016-12-29 2019-01-08 山西振东基赛生物科技有限公司 试管架及生物物质分离组件
KR20190097336A (ko) * 2018-02-09 2019-08-21 주식회사 파나진 핵산증폭 반응용 용기 및 이를 이용한 핵산증폭반응장치
CN108413715A (zh) * 2018-03-07 2018-08-17 苏州布莱尔仪器有限公司 一种热均匀性冻干机托盘

Patent Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US5522155A (en) * 1994-08-19 1996-06-04 W. L. Gore & Associates, Inc. Vented vial method of minimizing contamination of freeze-dried products
US5937536A (en) * 1997-10-06 1999-08-17 Pharmacopeia, Inc. Rapid drying oven for providing rapid drying of multiple samples
US6419827B1 (en) 1998-10-29 2002-07-16 Applera Corporation Purification apparatus and method
US8516714B2 (en) * 2008-01-21 2013-08-27 Intervet International B.V. Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles
US8528225B2 (en) * 2009-12-11 2013-09-10 Wyssmont Company Inc. Apparatus and method for continuous lyophilization
US8793896B2 (en) * 2010-02-01 2014-08-05 Adixen Vacuum Products Device and method for controlling a dehydration operation during a freeze-drying treatment
AU2016208368B2 (en) 2010-08-06 2019-05-02 Hospira Australia Pty Ltd Vial preparation method and system
US20130025298A1 (en) 2011-07-28 2013-01-31 Biocision, Inc. Preventing sample degradation from transient temperature fluctuations
KR20150009982A (ko) * 2012-05-03 2015-01-27 쇼오트 아게 의료, 제약 또는 화장품 어플리케이션들을 위한 물질들을 저장하기 위한 컨테이너들을 처리하기 위한 방법 및 장치
US9522752B2 (en) * 2012-05-03 2016-12-20 Schott Ag Process and apparatus for treating containers for storing substances for medical, pharmaceutical or cosmetic applications
CN110180607B (zh) 2013-03-14 2020-08-04 简·探针公司 用于执行自动试剂分析的系统、方法和设备
CN110180607A (zh) 2013-03-14 2019-08-30 简·探针公司 用于执行自动试剂分析的系统、方法和设备
US10781003B2 (en) 2013-08-16 2020-09-22 Vanrx Pharmasystems Inc. Method, system, and apparatus for pharmaceutical container filing and lyophilizing
US20150108034A1 (en) 2013-10-21 2015-04-23 Schott Ag Supporting structure for supporting containers for substances for medical, pharmaceutical or cosmetic applications as well as transport and packaging container comprising the same
CN106461327A (zh) 2014-06-09 2017-02-22 泰尔茂比司特公司 冻干法
CN106461327B (zh) 2014-06-09 2019-12-13 泰尔茂比司特公司 冻干法
US10869848B2 (en) * 2014-11-14 2020-12-22 Navinta Iii Inc Carmustine pharmaceutical composition
US10342769B2 (en) * 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
US20190285342A1 (en) 2015-09-22 2019-09-19 Millrock Technology, Inc. Apparatus and method for developing freeze drying protocols using small batches of product
WO2017137637A2 (en) * 2016-08-05 2017-08-17 Bachem Holding Ag Drying container
US11377276B2 (en) * 2016-08-05 2022-07-05 Bachem Holding Ag Drying container
JP6944991B2 (ja) * 2016-08-05 2021-10-06 バッヘン・ホールディング・アクチエンゲゼルシャフト 乾燥容器
EP3494349B1 (de) * 2016-08-05 2020-10-07 Bachem AG Deckel für trocknungsbehälter
US10085971B2 (en) * 2016-08-22 2018-10-02 Navinta Iii Inc Pharmaceutical solution of asenapine for sublingual or buccal use
US20180148222A1 (en) 2016-11-30 2018-05-31 Schott Ag Supporting structure for concurrently supporting a plurality of vials, use thereof and process for the treatment of such vials
EP3499160A1 (de) 2017-12-15 2019-06-19 Martin Christ Gefriertrocknungsanlagen GmbH Gefriertrockner, gefriertrocknungsanlage, verfahren zum betrieb eines gefriertrockners und neue verwendung eines schlittens
US11359860B2 (en) * 2018-09-10 2022-06-14 Michael B. McNeil Herb essential oil processing equipment
US11243029B2 (en) * 2019-04-26 2022-02-08 Purdue Research Foundation Process monitoring and control for lyophilization using a wireless sensor network
US11054185B1 (en) * 2020-02-24 2021-07-06 Lyophilization Technology, Inc. Apparatus for lyophilization of products contained in product delivery units
US20210325110A1 (en) * 2020-04-15 2021-10-21 Navinta Iii Inc Lyophilization Promoting Element

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Barron, Randall F. and Brian R. Barron. Design for Thermal Stresses. John Wiley & Sons, Inc. 2012. [Retrieved Jun. 18, 2021). Retrieved from the internet: <URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/97811 18093184.app2> Appendix B.
Catalent Biologies website; "Vial Filling & Lyophilization"; downloaded from internet on Apr. 14, 2021. https://biologics.catalent.com/biologics/drug-product/vial-filling-lyophilization/.
Graberg S, Hyla W, Gieseler H. Freeze Drying from small product containers to its implication on freeze-drying process design: evaluation of heat transfer coefficient of a new 96-well freeze drying system in comparison to 2R tubing vials and polypropylene 96-well PCR-plates. CPPR Freeze Drying of Pharmaceuticals and Biologicals. Breckenridge, Colorado; 2008.
International Search Report & Written Opinion of the International Searching Authority Application No. PCT/US2021/027435 Completed: Jun. 18, 2021; dated Aug. 13, 2021 15 pages.
Levenspiel, O., 2014. Engineering Flow and Heat Exchange. 3rd ed. Corvallis: Springer, p. 179.
Patel, S. and Pikal, M., 2010. Freeze-Drying in Novel Container System: Characterization of Heat and Mass Transfer in Glass Syringes. Journal of Pharmaceutical Sciences, 99(7), pp. 3188-3204.
Pikal, M., Bogner, R., Mudhivarthi, V., Sharma, P. and Sane, P., 2016. Freeze-Drying Process Development and Scale-Up: Scale-Up of Edge Vial Versus Center Vial Heat Transfer Coefficients, K v. Journal of Pharmaceutical Sciences, 105(11), pp. 3333-3343.
Rambhatla, S. and Pikal, M., 2003. Heat and mass transfer scale-up issues during freeze-drying, I: Atypical radiation and the edge vial effect. AAPS PharmSciTech, 4(2), pp. 22-23.
Shah, Ramesh K. and Dusan P. Sekulic. Fundamentals of Heat Exchanger Design. John Wiley & Sons, Inc. 2003. [Retrieved Jun. 18, 2021). Retrieved from the internet: <URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/9780470172605.app1> Appendix A.
Von Graberg. Freeze Drying from Small Containers: Heat and Mass Transfer and Implications on Process Design. Friedrich-Alexander-University Er1angen-Nurnberg. Jul. 28, 2011 (Jul. 28, 2011 ) [Retrieved Jun. 18, 2010 ]. Retrieved from the internet: <URL: https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docld/1882> pp. 5, 6, 40-44.
Werk, T., Ludwig, I., Luernkemann, J., Huwyler, J., Mahler, H., Haeuser, C. and Hafner, M., 2016. New Processes for Freeze-Drying in Dual-Chamber Systems. PDA Journal of Pharmaceutical Science and Technology, 70(3), pp. 191-207.

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230040871A1 (en) * 2020-02-24 2023-02-09 Candry Technologies Inc. Dehydrating apparatus and method
US12557823B2 (en) * 2020-02-24 2026-02-24 Candry Technologies Inc. Dehydrating apparatus and method
US20220307767A1 (en) * 2021-03-24 2022-09-29 Torsten Pächnatz Freeze drying plant and method
US12416448B2 (en) * 2021-03-24 2025-09-16 Torsten Pächnatz Freeze drying plant and method
US12379157B2 (en) * 2022-06-28 2025-08-05 Compliance Consulting And Engineering Services, S.L. System for controlling the freeze-drying process in a freeze dryer with a plate stack system and a method for generating a design space

Also Published As

Publication number Publication date
US20210325110A1 (en) 2021-10-21
WO2021211806A1 (en) 2021-10-21
EP4135516A4 (de) 2024-07-31
EP4135516A1 (de) 2023-02-22

Similar Documents

Publication Publication Date Title
US11732964B2 (en) Lyophilization promoting element
US10017294B2 (en) Transport and packaging container for accommodating a plurality of containers for medical, pharmaceutical or cosmetic applications as well as methods and uses thereof
US10703539B2 (en) Supporting structure for concurrently supporting a plurality of vials, use thereof and process for the treatment of such vials
US10287056B2 (en) Holding structure for concurrently holding a plurality of containers for substances for medical, pharmaceutical or cosmetic applications as well as transport or packaging container comprising the same
US9828124B2 (en) Process and apparatus for treating containers for storing substances for medical, pharmaceutical or cosmetic applications
CN104272049B (zh) 用于处理存储医疗、药物或化妆品应用的物质的容器的方法
CN104555014B (zh) 用于支撑容器的支撑结构及包括它的运输和包装容器
US6440101B1 (en) Syringe systems for lyophilized drugs and methods for making the same
JP7049373B2 (ja) 製品を真空凍結乾燥するためのプロセス
US8544183B2 (en) Thermal shielding to optimize lyophilization process for pre-filled syringes or vials
PT812411E (pt) Processo e aparelho para liofilizacao
US20190041132A1 (en) Vented cover plate for an array of syringes
DE102012110339B4 (de) Haltestruktur zum gleichzeitigen Halten einer Mehrzahl von medizinischen oder pharmazeutischen Behältern sowie Transport- oder Verpackungsbehälter mit Selbiger und Verfahren zur Behandlung solcher Behälter
JP3904342B2 (ja) 凍結真空乾燥装置
Werk et al. New processes for freeze-drying in dual chamber systems
US20100251560A1 (en) Holder
JP2019184152A (ja) ホルダ及び凍結乾燥システム
US20240409270A1 (en) Methods and assemblies for packaging containers for compositions containing active ingredients
Matejčíková et al. Impact of packing density on primary drying rate
CA2215748C (en) Freeze-drying process and apparatus
CN218627509U (zh) 适用于锥底保存管的冻干装置
HK1238128A1 (zh) 在初级包装容器中提供含有活性药物成份的乾燥固体产品的方法

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

AS Assignment

Owner name: NAVINTA III INC, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PATEL, MAHENDRA R.;PATEL, SANDIPKUMAR ARVINDBHAI;SIGNING DATES FROM 20210322 TO 20210324;REEL/FRAME:056079/0781

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: PROVIDENT BANK, NEW JERSEY

Free format text: SECURITY INTEREST;ASSIGNORS:NAVINTA III INC;NAVINTA NV, INC;NAVINTA, LLC;REEL/FRAME:066706/0324

Effective date: 20240305